City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…
On Nov. 8, 2007, researchers from Brigham and Women’s and MIT’s Broad Institute and Harvard discovered a gene…
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
On Nov. 10, 1998, Immunex announced that ENBREL(tm) (etanercept) had received approval from the U.S. Food and Drug…
In 1998, Immunex dedicated its new manufacturing and development center. The 100,000 square foot complex broke ground in…
On Apr. 16, 1992, a controlled trial of showed low-dose methotrexate to be effective in resistant Juvenile rheumatoid…
On Dec. 7, 1953, the U.S. Food and Drug Administration (FDA) approved methotrexate, an antimetabolite derived from folic…
In 1950, Drs. Edward C. Kendall and Philip S. Hench at the Mayo Clinic, along with Tadeus Reichstein,…
On Sept. 21, 1948, a 28-year-old woman at Saint Marys Hospital (Mayo Clinic) in Rochester, MN received the…
In 1946, The Canadian Red Cross Memorial Hospital,Taplow, Berkshire, was built as a hospital for children which would…